Described herein is a method of determining the presence of a nucleoside reverse transcriptase inhibitor-resistant Human Immunodeficiency Virus- 1 (HIV-I) virus particle in a biological sample, comprising identifying the presence in the sample of a point mutation at codon Q509 of an HIV-I reverse transcriptase, for example and without limitation Q509L. That point mutation increases resistance to AZT about 3- to 10-fold by itself and about 50-fold in combination with the connection domain mutation A371 V.
申请公布号
WO2007089692(A3)
申请公布日期
2008.04.10
申请号
WO2007US02369
申请日期
2007.01.30
申请人
UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION;MELLORS, JOHN, W.;KOONTZ, DIANNA;BREHM, JESSICA, H.
发明人
MELLORS, JOHN, W.;KOONTZ, DIANNA;BREHM, JESSICA, H.